OPKO Health, Inc.
OPKO Health, Inc., a prominent player in the biotechnology and diagnostics industry, is headquartered in the United States. Founded in 2007, the company has rapidly evolved, focusing on innovative solutions in pharmaceuticals, diagnostics, and laboratory services. OPKO is particularly known for its cutting-edge products, including the 4Kscore® test for prostate cancer and its proprietary growth hormone therapies, which set it apart in the competitive healthcare landscape. With a strong presence in the US and expanding operations in international markets, OPKO Health has achieved significant milestones, including strategic partnerships and acquisitions that enhance its product offerings. The company’s commitment to advancing healthcare through research and development has solidified its position as a leader in the industry, making it a key player in the ongoing evolution of medical diagnostics and therapeutics.
DitchCarbon Score
How does OPKO Health, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Business Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
OPKO Health, Inc.'s score of 23 is higher than 57% of the industry. This can give you a sense of how well the company is doing compared to its peers.
OPKO Health, Inc.'s reported carbon emissions
OPKO Health, Inc., headquartered in the US, currently does not have publicly available carbon emissions data or specific reduction targets. As a result, there are no reported figures for their Scope 1, 2, or 3 emissions. The company has not outlined any formal climate commitments or initiatives aimed at reducing carbon emissions. In the context of the healthcare industry, many companies are increasingly focusing on sustainability and climate action, but OPKO Health, Inc. has yet to disclose its strategies or targets in this area.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
OPKO Health, Inc. is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
